Quick Answer
BIO-TECHNE Corp reported Cash And Cash Equivalents At Carrying Value of $162.19 million for the year ending 2025.
- BIO-TECHNE Corp showed an increase of +6.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from BIO-TECHNE Corp's annual report (Form 10-K), filed with the SEC on August 22, 2025.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2008 to 2025), BIO-TECHNE Corp's Cash And Cash Equivalents At Carrying Value has declined by 2.9%.
- Historical annual values: Fiscal year 2025: $162.19 million | Fiscal year 2024: $151.79 million | Fiscal year 2023: $180.57 million | Fiscal year 2022: $172.57 million | Fiscal year 2021: $199.09 million | Fiscal year 2020: $146.63 million | Fiscal year 2019: $100.89 million | Fiscal year 2018: $121.99 million | Fiscal year 2017: $91.61 million | Fiscal year 2016: $64.24 million | Fiscal year 2015: $54.53 million | Fiscal year 2014: $318.57 million | Fiscal year 2013: $163.79 million | Fiscal year 2012: $116.68 million | Fiscal year 2011: $77.61 million | Fiscal year 2010: $94.14 million | Fiscal year 2009: $160.94 million | Fiscal year 2008: $166.99 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: